Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy

被引：0
|
作者：
Ohtsuka, T. [1 ]
Uetani, T. [1 ]
Saito, M. [1 ]
Inaba, S. [1 ]
Nagai, T. [1 ]
Nishimura, K. [1 ]
Kurata, A. [1 ]
Ogimoto, A. [1 ]
Okayama, H. [1 ]
Higaki, J. [1 ]
机构：
[1] Ehime Univ, Dept Internal Med 2, Matsuyama, Ehime 790, Japan
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [21] Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy
    Li, Xinyi
    Zhang, Xiaonan
    Zeng, Zhigang
    Mai, Wenzhi
    Peng, Zishan
    Li, Binjia
    Hong, Wanzi
    Liu, Yaoxin
    Shu, Fen
    Tang, Jiehua
    Xu, Lishu
    Tan, Ning
    Ma, Jinjin
    Jiang, Lei
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (10) : 752 - 757
  • [22] Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy
    Goldenberg, Ido
    Younis, Arwa
    Huang, David T.
    Rosero, Spencer
    Kutyifa, Valentina
    McNitt, Scott
    Polonsky, Bronislava
    Steinberg, Jonathan S.
    Zareba, Wojciech
    Goldenberg, Ilan
    Aktas, Mehmet K.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025, 36 (01) : 188 - 197
  • [23] Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis
    Bauer, Alicja
    Habior, Andrzej
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Serum Level of Matrix Metalloproteinase-3 in Patients with Oral Lichen Planus
    Farzin, M.
    Mardani, M.
    Ghabanchi, J.
    Fattahi, M. J.
    Rezaee, M.
    Heydari, S. T.
    Tadbir, A. Andisheh
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2012, 14 (01) : 10 - 13
  • [25] Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma
    Faruk Tas
    Derya Duranyildiz
    Hilal Oguz
    Rian Disci
    Sidika Kurul
    Vildan Yasasever
    Erkan Topuz
    Medical Oncology, 2005, 22 : 39 - 44
  • [26] Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma
    Tas, F
    Duranyildiz, D
    Oguz, H
    Disci, R
    Kurul, S
    Yasasever, V
    Topuz, E
    MEDICAL ONCOLOGY, 2005, 22 (01) : 39 - 44
  • [27] Serum levels of matrix metalloproteinase-3 in undifferentiated spondyloarthropathy
    Chen, C-H
    Liao, H-T
    Chen, H-A
    Liang, T-H
    Wang, H-P
    Chou, C-T
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2007, 36 (04) : 326 - 328
  • [28] Emerging Techniques for Risk Stratification in Nonischemic Dilated Cardiomyopathy JACC Review Topic of the Week
    Marrow, Benjamin A.
    Cook, Stuart A.
    Prasad, Sanjay K.
    McCann, Gerry P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (10) : 1196 - 1207
  • [29] The significance of serum matrix metalloproteinase-3 (MMP-3) levels in hemodialysis patients
    Naganama, T.
    Sugimura, K.
    Uchida, J.
    Tashiro, K.
    Kitamoto, K.
    Iwai, T.
    Yoshimura, R.
    Machida, Y.
    Kuroki, Y.
    Tsuchida, K.
    Takemoto, Y.
    Nakatani, T.
    BLOOD PURIFICATION, 2006, 24 (5-6) : 471 - 472
  • [30] ELEVATION OF SERUM MATRIX METALLOPROTEINASE-3 IN A GROUP OF RHEUMATOID ARTHRITIS ALGERIAN PATIENTS
    Fodil, D.
    Salah, S. S.
    Benidir, M.
    Adjabi, S.
    Abbadi, M. C.
    Attal, N.
    Bayou, M.
    Mostefai, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 880 - 880
12345